FDA Inspection 796372 — Medefil Incorporated
The FDA completed an inspection of Medefil Incorporated on Aug 22, 2012 in Glendale Heights, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 22, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Glendale Heights, IL (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)